Chandak Nagargoje Superspeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 1.20 M
- Company Age 6 Year, 21 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.25 Cr
- Revenue Growth 612.25%
- Profit Growth 17.33%
- Ebitda 302.61%
- Net Worth 989.59%
- Total Assets 12.92%
About Chandak Nagargoje Superspeciality Hospital
Chandak Nagargoje Superspeciality Hospital Private Limited (CNSHPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2019 (Six years 21 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹3.25 Cr.
Vishal Chandak and Ramdas Nagargoje serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85300MH2019PTC320212
-
Company No.
320212
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jan 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Chandak Nagargoje Superspeciality Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Chandak
|
Director | 25-Jan-2019 | Current |
|
Ramdas Nagargoje
|
Director | 25-Jan-2019 | Current |
Financial Performance of Chandak Nagargoje Superspeciality Hospital.
Chandak Nagargoje Superspeciality Hospital Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 612.25% increase. The company also saw a substantial improvement in profitability, with a 17.33% increase in profit. The company's net worth Soared by an impressive increase of 989.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chandak Nagargoje Superspeciality Hospital?
In 2020, Chandak Nagargoje Superspeciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹32.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2019 | Others | ₹3.25 Cr | Open |
How Many Employees Work at Chandak Nagargoje Superspeciality Hospital?
Unlock and access historical data on people associated with Chandak Nagargoje Superspeciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chandak Nagargoje Superspeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandak Nagargoje Superspeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.